Key result
A 12-week supervised exercise program did not change asymmetric dimethylarginine or uric acid levels in adults with CHD-associated pulmonary hypertension.
Why the study?
Exercise-based rehabilitation may improve functional outcomes in pulmonary hypertension, but its effects on endothelial and metabolic biomarkers such as asymmetric dimethylarginine and uric acid in adults with congenital heart disease-associated pulmonary hypertension were uncertain.
Does a 12-week supervised exercise program alter asymmetric dimethylarginine and uric acid levels in adults with congenital heart disease-associated pulmonary hypertension?
Does a 12-week supervised exercise program alter asymmetric dimethylarginine and uric acid levels in adults with congenital heart disease-associated pulmonary hypertension?
Answers are grounded in this paper and cite their sources.
A 12-week supervised moderate-intensity exercise program did not produce statistically significant changes in endothelial or metabolic biomarkers (asymmetric dimethylarginine and uric acid) in a small cohort of adults with congenital heart disease-associated pulmonary hypertension.
Exercise-based rehabilitation may improve functional outcomes in pulmonary hypertension, but its effects on endothelial and metabolic biomarkers in adults with congenital heart disease-associated pulmonary hypertension remain uncertain. This study evaluated the influence of a 12-week exercise program on asymmetric dimethylarginine and uric acid levels. This single-arm pre-post interventional study included 13 adults with congenital heart disease-associated pulmonary hypertension. Participants completed supervised moderate-intensity aerobic exercise twice weekly for 12 weeks, at 40%–60% of heart rate reserve for 30 minutes per session, with daily incentive spirometry. Asymmetric dimethylarginine and uric acid levels were measured at baseline and week 12 and compared using paired-samples t tests. Participants had a mean age of 32.92 ± 8.22 years, and 76.9% were female. Mean asymmetric dimethylarginine decreased from 20,933.27 ng/L at baseline to 18,518.38 ng/L at week 12; this difference was not statistically significant (t = 0.610, p = 0.553). Mean uric acid increased from 7.76 to 8.27 mg/dL, also without a statistically significant difference (t = -2.027, p = 0.066). A 12-week supervised exercise program was not associated with statistically significant changes in asymmetric dimethylarginine or uric acid levels in adults with congenital heart disease-associated pulmonary hypertension. The differing directional responses suggest that endothelial and metabolic adaptations to exercise may vary within this population.
No takes yet. Share an insight, caveat, or question.
Ricky Kurniawan Pratama (2026) studied Congenital heart disease-associated pulmonary hypertension (n=13). Supervised moderate-intensity aerobic exercise with daily incentive spirometry vs. Baseline (pre-intervention) was evaluated on Changes in asymmetric dimethylarginine and uric acid levels at week 12 (t = 0.610 (ADMA); t = -2.027 (uric acid), p=0.553 (ADMA); 0.066 (uric acid)). A 12-week supervised exercise program did not change asymmetric dimethylarginine or uric acid levels in adults with CHD-associated pulmonary hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: